IAG Wealth Partners’s Quest Diagnostics DGX Stock Holding History

IAG Wealth Partners’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$784	Hold	4	–	–	﹤0.01%	490
2025 Q4	$694	Hold	4	–	–	﹤0.01%	475
2025 Q3	$762	Hold	4	–	–	﹤0.01%	490
2025 Q2	$719	Hold	4	–	–	﹤0.01%	465
2025 Q1	$677	Hold	4	–	–	﹤0.01%	478
2024 Q4	$603	Hold	4	–	–	﹤0.01%	490
2024 Q3	$621	Buy	+4	New	+$597	﹤0.01%	473

Other funds holding DGX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

EIG

EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

IAG Wealth Partners's DGX Position: Q1 2026 in Review

IAG Wealth Partners held its Quest Diagnostics (DGX) position steady in Q1 2026 at 4 shares worth $784. The position accounts for ﹤0.01% of the portfolio, ranked #490.

IAG Wealth Partners first reported a position in DGX in Q3 2024 and has held it in 7 quarters since. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

IAG Wealth Partners held 4 shares of Quest Diagnostics worth $784 as of Q1 2026.
IAG Wealth Partners left its Quest Diagnostics share count unchanged in Q1 2026.
Quest Diagnostics made up ﹤0.01% of IAG Wealth Partners's portfolio in Q1 2026, its #490 holding.
IAG Wealth Partners first reported a position in Quest Diagnostics in Q3 2024 and has held it in 7 quarters since.
1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on IAG Wealth Partners's 13F filing for Q1 2026, filed 29 Apr 2026.